Literature DB >> 11547381

Vancomycin-resistant Enterococcus infected total knee arthroplasty.

M D Ries1.   

Abstract

Use of vancomycin to treat infections and hospital colonization with methicillin-resistant Staphylococcus aureus has contributed to the development of vancomycin resistance in Enterococcus. Postoperative infection with vancomycin-resistant Enterococcus developed in 2 patients after total knee arthroplasty, indicating that the infections were nosocomial. Both patients required multiple procedures. The infections were controlled with serial open débridements. One knee was fused successfully, and the other was managed with resection arthroplasty.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11547381     DOI: 10.1054/arth.2001.24951

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  5 in total

1.  Knee arthrodesis with a long intramedullary nail as limb salvage for complex periprosthetic infections.

Authors:  Nima Razii; Ammar M I Abbas; Rahul Kakar; Sanjeev Agarwal; Rhidian Morgan-Jones
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-07-29

2.  Low rate of infection control in enterococcal periprosthetic joint infections.

Authors:  Mohammad R Rasouli; Mohan S Tripathi; Robert Kenyon; Nathan Wetters; Craig J Della Valle; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

3.  Prosthetic knee infection by resistant bacteria: the worst-case scenario.

Authors:  Michele Vasso; Alfredo Schiavone Panni; Ivan De Martino; Giorgio Gasparini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-02-01       Impact factor: 4.342

4.  Management of Resistant, Atypical and Culture-negative Periprosthetic Joint Infections after Hip and Knee Arthroplasty.

Authors:  Alexander S McLawhorn; Danyal H Nawabi; Amar S Ranawat
Journal:  Open Orthop J       Date:  2016-11-30

5.  Distribution characteristics of Staphylococcus spp. in different phases of periprosthetic joint infection: A review.

Authors:  Geyong Guo; Jiaxing Wang; Yanan You; Jiaqi Tan; Hao Shen
Journal:  Exp Ther Med       Date:  2017-04-04       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.